DIN 02526263 — PALYNZIQ 20 MG
PALYNZIQ is a solution of Pegvaliase marketed by BIOMARIN INTERNATIONAL LIMITED. The full Pegvaliase monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02526263
- Brand name
- PALYNZIQ
- Active ingredient
- Pegvaliase
- Strength
- 20 MG
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- BIOMARIN INTERNATIONAL LIMITED
- Health Canada status
- MARKETED
- Drug class
- Metabolic enzyme substitution therapy (pegylated recombinant phenylalanine ammonia lyase)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Pegvaliase products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02526255 | PALYNZIQ | 10 MG | SOLUTION | BIOMARIN INTERNATIONAL LIMITED | MARKETED |
| 02526247 | PALYNZIQ | 2.5 MG | SOLUTION | BIOMARIN INTERNATIONAL LIMITED | MARKETED |